secwatch.observer — SEC 8-K summary
======================================

Issuer:     MEDIFAST INC (MED)
CIK:        0000910329
Form:       8-K
Filed at:   2022-08-03T23:59:59+00:00
Accession:  0001628280-22-020596
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medifast Q2 revenue up 15% to $453.3M, net income down 16.7%; cuts full-year guidance on macro headwinds
--------------------------------------------------------------------------------

- Revenue $453.3M (+15% YoY); net income $39.1M (-16.7%); adjusted EPS $3.87 (-2.5%).
- Active earning coaches 68,000 (+14.9%); revenue per coach $6,667 slightly above prior year.
- Gross margin 71.0% vs 74.5% YoY due to customer acquisition costs and higher raw ingredient costs.
- Entered $100M accelerated share repurchase; quarterly dividend $1.64/share.
- Full-year 2022 guidance lowered: revenue $1.58B-$1.66B (prev. $1.78B-$1.84B); adjusted EPS $12.70-$14.10 (prev. $14.60-$16.05) due to inflation and consumer sentiment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/910329/000162828022020596/0001628280-22-020596-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/910329/000162828022020596/med-20220803.htm
  HTML page:      https://secwatch.observer/filing/0001628280-22-020596

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer